Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Logo for

J. Biol. Chem. 275 (36): 27520-27530

© 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Lipid Phosphate Phosphatase-1 and Ca2+ Control Lysophosphatidate Signaling through EDG-2 Receptors*

James Xu, Lana M. LoveDagger , Indrapal Singh, Qiu-Xia Zhang, Jay Dewald, De-An Wang§, David J. Fischer§, Gabor Tigyi§, Luc G. Berthiaume||, David W. Waggoner**, and David N. BrindleyDagger Dagger

From the Departments of Biochemistry (Signal Transduction Laboratories and Lipid Biology Research Group) and || Cell Biology, University of Alberta, Edmonton, Alberta T6G 2S2, Canada, the § Department of Physiology, University of Tennessee, Memphis, Tennessee 38163, and ** Cell Therapeutics Inc., Seattle, Washington 98119

The serum-derived phospholipid growth factor, lysophosphatidate (LPA), activates cells through the EDG family of G protein-coupled receptors. The present study investigated mechanisms by which dephosphorylation of exogenous LPA by lipid phosphate phosphatase-1 (LPP-1) controls cell signaling. Overexpressing LPP-1 decreased the net specific cell association of LPA with Rat2 fibroblasts by approximately 50% at 37 °C when less than 10% of LPA was dephosphorylated. This attenuated cell activation as indicated by diminished responses, including cAMP, Ca2+, activation of phospholipase D and ERK, DNA synthesis, and cell division. Conversely, decreasing LPP-1 expression increased net LPA association, ERK stimulation, and DNA synthesis. Whereas changing LPP-1 expression did not alter the apparent Kd and Bmax for LPA binding at 4 °C, increasing Ca2+ from 0 to 50 µM increased the Kd from 40 to 900 nM. Decreasing extracellular Ca2+ from 1.8 mM to 10 µM increased LPA binding by 20-fold, shifting the threshold for ERK activation to the nanomolar range. Hence the Ca2+ dependence of the apparent Kd values explains the long-standing discrepancy of why micromolar LPA is often needed to activate cells at physiological Ca2+ levels. In addition, the work demonstrates that LPP-1 can regulate specific LPA association with cells without significantly depleting bulk LPA concentrations in the extracellular medium. This identifies a novel mechanism for controlling EDG-2 receptor activation.

* This work was supported by grants (to D. N. B.) from Cell Therapeutics Inc., by the Alberta Heritage Foundation for Medical Research, by Medical Research Council of Canada Grant MT 10504, and by National Institutes of Health Grant RO1 61751 (to D. English and D. N. B.) and United States Public Health Service Grant HL 61469 (to G. T.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a Graduate Studentship from the Alberta Heritage Foundation for Medical Research.

Established Investigator of the American Heart Association.

Dagger Dagger Recipient of a Medical Scientist Award. To whom correspondence should be addressed: Dept. of Biochemistry, 357 Heritage Medical Research Centre, University of Alberta, Edmonton, Alberta T6G 2S2, Canada. Tel.: 780-492-2078; Fax: 780-492-3383; E-mail:

Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Phosphatidic acid mediates activation of mTORC1 through the ERK signaling pathway.
J. N. Winter, T. E. Fox, M. Kester, L. S. Jefferson, and S. R. Kimball (2010)
Am J Physiol Cell Physiol 299, C335-C344
   Abstract »    Full Text »    PDF »
Cyclic Phosphatidic Acid Is Produced by Autotaxin in Blood.
S. Tsuda, S. Okudaira, K. Moriya-Ito, C. Shimamoto, M. Tanaka, J. Aoki, H. Arai, K. Murakami-Murofushi, and T. Kobayashi (2006)
J. Biol. Chem. 281, 26081-26088
   Abstract »    Full Text »    PDF »
Cell density-dependent expression of EDG family receptors and mesangial cell proliferation: role in lysophosphatidic acid-mediated cell growth.
Y. Xing, S. H. Ganji, J. W. Noh, and V. S. Kamanna (2004)
Am J Physiol Renal Physiol 287, F1250-F1257
   Abstract »    Full Text »    PDF »
Lipid Phosphate Phosphatases Regulate Lysophosphatidic Acid Production and Signaling in Platelets: STUDIES USING CHEMICAL INHIBITORS OF LIPID PHOSPHATE PHOSPHATASE ACTIVITY.
S. S. Smyth, V. A. Sciorra, Y. J. Sigal, Z. Pamuklar, Z. Wang, Y. Xu, G. D. Prestwich, and A. J. Morris (2003)
J. Biol. Chem. 278, 43214-43223
   Abstract »    Full Text »    PDF »
Role of Decreased Levels of Lipid Phosphate Phosphatase-1 in Accumulation of Lysophosphatidic Acid in Ovarian Cancer.
J. L. Tanyi, Y. Hasegawa, R. Lapushin, A. J. Morris, J. K. Wolf, A. Berchuck, K. Lu, D. I. Smith, K. Kalli, L. C. Hartmann, et al. (2003)
Clin. Cancer Res. 9, 3534-3545
   Abstract »    Full Text »    PDF »
Identification of a Phosphothionate Analogue of Lysophosphatidic Acid (LPA) as a Selective Agonist of the LPA3 Receptor.
Y. Hasegawa, J. R. Erickson, G. J. Goddard, S. Yu, S. Liu, K. W. Cheng, A. Eder, K. Bandoh, J. Aoki, R. Jarosz, et al. (2003)
J. Biol. Chem. 278, 11962-11969
   Abstract »    Full Text »    PDF »
The Human Lipid Phosphate Phosphatase-3 Decreases the Growth, Survival, and Tumorigenesis of Ovarian Cancer Cells: Validation of the Lysophosphatidic Acid Signaling Cascade as a Target for Therapy in Ovarian Cancer.
J. L. Tanyi, A. J. Morris, J. K. Wolf, X. Fang, Y. Hasegawa, R. Lapushin, N. Auersperg, Y. J. Sigal, R. A. Newman, E. A. Felix, et al. (2003)
Cancer Res. 63, 1073-1082
   Abstract »    Full Text »    PDF »
Injury-elicited differential transcriptional regulation of phospholipid growth factor receptors in the cornea.
D.-A. Wang, H. Du, J. H. Jaggar, D. N. Brindley, G. J. Tigyi, and M. A. Watsky (2002)
Am J Physiol Cell Physiol 283, C1646-C1654
   Abstract »    Full Text »    PDF »
Increased Production of Bioactive Lysophosphatidic Acid by Serum Lysophospholipase D in Human Pregnancy.
A. Tokumura, Y. Kanaya, M. Miyake, S. Yamano, M. Irahara, and K. Fukuzawa (2002)
Biol Reprod 67, 1386-1392
   Abstract »    Full Text »    PDF »
Expression of Ectolipid Phosphate Phosphohydrolases in 3T3F442A Preadipocytes and Adipocytes. INVOLVEMENT IN THE CONTROL OF LYSOPHOSPHATIDIC ACID PRODUCTION.
M. F. Simon, A. Rey, I. Castan-Laurel, S. Gres, D. Sibrac, P. Valet, and J. S. Saulnier-Blache (2002)
J. Biol. Chem. 277, 23131-23136
   Abstract »    Full Text »    PDF »
Molecular cloning and expression of pulmonary lipid phosphate phosphohydrolases.
M. Nanjundan and F. Possmayer (2001)
Am J Physiol Lung Cell Mol Physiol 281, L1484-L1493
   Abstract »    Full Text »    PDF »
Platelet-released phospholipids link haemostasis and angiogenesis.
D. English, J. G.N. Garcia, and D.N. Brindley (2001)
Cardiovasc Res 49, 588-599
   Abstract »    Full Text »    PDF »
G-protein-coupled Receptor Stimulation of the p42/p44 Mitogen-activated Protein Kinase Pathway Is Attenuated by Lipid Phosphate Phosphatases 1, 1a, and 2 in Human Embryonic Kidney 293 Cells.
F. Alderton, P. Darroch, B. Sambi, A. McKie, I. S. Ahmed, N. Pyne, and S. Pyne (2001)
J. Biol. Chem. 276, 13452-13460
   Abstract »    Full Text »    PDF »
Lysophosphatidic Acid-induced Mitogenesis Is Regulated by Lipid Phosphate Phosphatases and Is Edg-receptor Independent.
S. B. Hooks, W. L. Santos, D.-S. Im, C. E. Heise, T. L. Macdonald, and K. R. Lynch (2001)
J. Biol. Chem. 276, 4611-4621
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882